Journal of Leukemia
Open Access

Burton's Tyrosine Kinase Inhibition by Ibrutinib: Current Status

Rohit Mathur

DOI: 10.4172/2329-6917.1000e113

G2/M Arrest Sensitises Erythroid Leukemia Cells to TRAIL-induced Apoptosis

Séverine Cruet-Hennequart, Tanja Paavilainen, Michael O’Dwyer, Réka Tóth, Michael P Carty, Afshin Samali and Eva Szegezdi

DOI: 10.4172/2329-6917.1000174

Occurrence of Non-Hodgkin Lymphoma after the Diagnosis of Persistent Polyclonal B-cell Lymphocytosis

Jean-Baptiste Méar, Xavier Troussard, Véronique Salaün, Hossein Mossafa, Gandhi Damaj, Cécile Le Naourès, Françoise Galateau-Sallé and Edouard Cornet

DOI: 10.4172/2329-6917.1000175

Application of Sensitive AlleleSEQR Chimerism PCR from Peripheral Blood in Allografted AML/MDS Patients Treated with Pre-emptive Posttransplant Immunomodulation

Urpu Salmenniemi, Veli Kairisto, Jussi Leino, Mervi Putkonen, Marjut Kauppila, Tommi Salmi, Markku Oksman, Kari Remes and Maija It?l?-Remes

DOI: 10.4172/2329-6917.1000176

Changes in Antigen Expression in a Follow-up of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Jiehao Zhou, Anupama Tewari, Mehdi Nassiri and Magdalena Czader

DOI: 10.4172/2329-6917.1000177

Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3+CD8+ T cells against Various Solid Tumors

Jooeun Bae, Derin B Keskin, Kristen Cowens, Ann-Hwee Lee, Glen Dranoff, Nikhil C Munshi and Kenneth C Anderson

DOI: 10.4172/2329-6917.1000178

B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, without the development of Richter's Syndrome, with Neoplastic Cells Lacking CD20 Antigen Expression after Rituximab Treatment

Shingo Yanagiya, Kazuya Sato, Nodoka Tsukada, Junki Inamura, Satoshi Ito, Motohiro Shindo, Keisuke Sato, Koji Sakurai, Eisuke Shiozawa, Toshiko Yamochi5, Hidekazu Ota and Takaaki Hosoki

Immune Thrombocytopenic Purpura Following Acute Lymphoblastic Leukemia in Remission

Olaniyi John A, Ogundeji Peter S and Ogbaro Daniel D

DOI: 10.4172/2329-6917.1000180

Chronic Lymphocytic Leukemia: Raising Expectations in the Treatment of Elderly Patients

Wolfgang Knauf and Daniel Re

DOI: 10.4172/2329-6917.1000181

Agranulocytosis as a Part of Secondary Graft Failure after Allogenic Stem Cell Transplantation

Bimalangshu R Dey and Sidhertha Podder

DOI: 10.4172/2329-6917.1000182

Paraprotein-related Bleeding as a First Symptom of Multiple Myeloma

Teresa Bot?n, Albert Oriol, Elisa Orna and Josep-Maria Ribera

DOI: 10.4172/2329-6917.1000183

Light Chain Multiple Myeloma: A Single Institution Series

Rafael Ríos-Tamayo, María José Sánchez, José Luís García de Veas, Teresa Rodríguez, José Manuel Puerta, Daysi-Yoe-Ling Chang, Pedro Antonio González, Carolina Alarcón-Payer, Antonio Romero, Miguel Ángel Calleja-Hernández, Pilar Garrido, Elisa López-Fern&

DOI: 10.4172/2329-6917.1000184

Acute Heart Failure in a Patient with Acute Myeloid Leukemia following Daunorubicin Treatment: a Case Report

Lawrence Druhan, Omotayo Fasan and Olivia R. Copelan

DOI: 10.4172/2329-6917.1000185

Approach to AML Treatment. Survey Results from the 6th International Hematologic Malignancies Conference: Bridging the gap 2015,Beijing,China

Kaiyan Liu, Pankaj Malhotra, Simrit Parmar, Raymond Wong, Steve Kornblau, Vikram Mathews, David Ritchie, Jiong Hu, Suraopl Issaragrisil, Borje Andersson, Elizabeth J Shpall, Richard Champlin and Xiao Jun Huang

DOI: 10.4172/2329-6917.1000186